MA09.02 Pembrolizumab + Carboplatin and Pemetrexed as 1st-Line Therapy for Advanced Non–Small Cell Lung Cancer: KEYNOTE-021 Cohort G
Year: 2017
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: Corey Langer, Shirish Gadgeel, Hossein Borghaei, Vassiliki Papadimitrakopoulou, Amita Patnaik, Steve Powell, Ryan Gentzler, Renato Martins, James Stevenson, Shadia Jalal, Amit Panwalkar, James Chih-Hsin Yang, Matthew Gubens, Lecia Sequist, Joseph Fiore, Joy Ge, Harry Raftopoulos, Leena Gandhi
Institutions: University of Pennsylvania, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Fox Chase Cancer Center, The University of Texas MD Anderson Cancer Center, South Texas Accelerated Research Therapeutics, University of South Dakota, University of Virginia Medical Center, University of Virginia, Seattle Cancer Care Alliance, Cleveland Clinic, Indiana University School of Medicine, National Taiwan University Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Harvard University, Massachusetts General Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2570157415